Columbus Oncology & Hematology Associates Inc

Columbus, Ohio 43214

0 studies enrolling now · 1 studies all time

What they study most

HER2-negative Breast Cancer

Studies at this site

• Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling — Status unconfirmed